You would think that given our extended stay at imec, we would have developed an extraordinary amount of data with regards to the tuning of those metrics.
You would be forgiven for thinking that although the 3rd platform lot failed, they quickly cooked up another non platform lot to appease stock holders (or whomever) knowing they could tune it up & put out the wicked numbers we now have. Which would have a reasonable value as is - right now. It seems we have cell production perfected, souped up, supercharged and on pointe.
I am anticipating an update on the short loop & / or mask before the end of this quarter. Look out above if either shows a whiff of success, and if not, I'm happy to play the long game till they get it right, in which case it could sell any time from here. Especially with a fully complimented and stacked A team running the show.
( Ps: Onya Jasp ! )
